Shereen Rafee
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 8
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Kenneth J. O’Byrne (6 shared papers)Yasir Y. Elamin (7 shared papers)Kathy Gately (3 shared papers)Stephen P. Finn (2 shared papers)Sinéad Cuffe (2 shared papers)Bryan T. Hennessy (5 shared papers)Sinéad Toomey (3 shared papers)Fábio Gomes (2 shared papers)
- Journals
- Cancer Microenvironment (2 papers)Cancer Research (2 papers)Journal of Translational Medicine (1 paper)European Archives of Oto-Rhino-Laryngology (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- IrelandAustraliaUnited Kingdom
In The Last Decade
Shereen Rafee
14 papers receiving 331 citations
Peers
Comparison fields: 5 of 56
- Oncology 123
- Otorhinolaryngology 14
- Cancer Research 36
- Molecular Biology 143
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Shereen Rafee
This map shows the geographic impact of Shereen Rafee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen Rafee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen Rafee more than expected).
Fields of papers citing papers by Shereen Rafee
This network shows the impact of papers produced by Shereen Rafee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen Rafee. The network helps show where Shereen Rafee may publish in the future.
Co-authors
The 25 scholars most cited alongside Shereen Rafee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 100 | |
| 2 | 2015 | 79 | |
| 3 | 2014 | 46 | |
| 4 | 2019 | 31 | |
| 5 | 2021 | 29 | |
| 6 | 2013 | 18 | |
| 7 | 2015 | 14 | |
| 8 | A rare case of nasopharyngeal carcinoma with widespread CNS metastases. | 2014 | 5 |
| 9 | 2022 | 4 | |
| 10 | Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement | 2015 | 2 |
| 11 | 2017 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2022 | 1 |
About Shereen Rafee
Shereen Rafee is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Epidemiology, having authored 14 papers that have together received 332 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (2 papers), Head and Neck Cancer Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (123 citations), Otorhinolaryngology (14 citations), Cancer Research (36 citations), Molecular Biology (143 citations) and Pulmonary and Respiratory Medicine (58 citations). Shereen Rafee has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Kenneth J. O’Byrne, Yasir Y. Elamin, Kathy Gately, Stephen P. Finn, Sinéad Cuffe, Bryan T. Hennessy, Sinéad Toomey, Fábio Gomes, Raffaele Califano and Christoph Ackermann. Their work appears in journals such as Cancer Microenvironment, Cancer Research, Journal of Translational Medicine, European Archives of Oto-Rhino-Laryngology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.